Effect of Monoclonal Antibody Blockade of Long Fragment Neurotensin on Weight Loss, Behavior, and Metabolic Traits After High-Fat Diet Induced Obesity

BackgroundObesity is a major public health problem of our time as a risk factor for cardiometabolic disease and the available pharmacological tools needed to tackle the obesity pandemic are insufficient. Neurotensin (NTS) is a 13 amino acid peptide, which is derived from a larger precursor hormone c...

Descripció completa

Dades bibliogràfiques

Autors principals:	Zherui Wu, Nicolas Stadler, Amazigh Abbaci, Jin Liu, Agnès Boullier, Nicolas Marie, Olivier Biondi, Marthe Moldes, Romain Morichon, Bruno Feve, Olle Melander, Patricia Forgez
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2021-10-01
Col·lecció:	Frontiers in Endocrinology
Matèries:	LF NTS targeted therapy neurotensin obesity behavior metabolism
Accés en línia:	https://www.frontiersin.org/articles/10.3389/fendo.2021.739287/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!